About this site
About This CJC-1295 Ipamorelin Monograph
An independent editorial project — a printed-style pharmacopoeia entry, not a clinic and not a vendor.
What this site is
CJC-Ipa Peptides is an independent editorial project that publishes summaries of the peer-reviewed research literature on the CJC-1295 Ipamorelin combination. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science, set in the register of a printed clinical monograph because that register fits the material: a careful, attributive reading of the record, with every claim sourced.
Why a monograph, not a clinic
The domain name reads like a generic peptide-stack catalogue term, and visitors often arrive expecting a vendor or an intake page. This site answers with the opposite. It is built as a monograph — running heads, numbered references, boxed cautions — precisely to keep the work documentary rather than promotional. That framing also enforces honesty about the central fact of this combination: the fixed CJC-1295 ipamorelin blend has never been tested in a controlled clinical trial, so every statement about "the stack" is attributed here to a study of a single component or to the general GHRH-plus-GHRP synergy literature, and never overstated.
Our editorial method
Each page leads with what was measured and attributes it to a named study; quantitative claims — doses, fold-changes, durations, half-lives — map to a numbered entry in the references. Doses are reported strictly as research observations (studied at this amount, in this species, by this route), never as a protocol for any person. We use only generic compound names and no drug brand names. Reported community effects are kept clearly separate from cited findings and are labeled anecdotal. Where a caution is theoretical, we say so.
What the name means
The "peptides" in CJC-Ipa Peptides is editorial framing — a position this publisher occupies relative to the literature on these two peptides, not a claim that the site supplies or compounds anything. There is no clinical team behind this site, no consultation service, and no prescription offered. The combination described here is not FDA-approved and is prohibited at all times in sport under WADA Section S2. This monograph exists to summarize and source the research, and to do nothing else.